Pharmaceutical Stability Consulting
ICH Q1A program design, stability strategy, excursion justification, and regulatory support.
Concentric helps pharmaceutical and life science organizations strengthen stability programs, chamber validation strategy, quality systems, SOPs, remediation programs, and inspection readiness.
Execution-level consulting aligned with ICH Q1A, 21 CFR Parts 210/211, USP <1079>, and inspection-ready quality system expectations.
Concentric is structured around the work that creates the most regulatory and operational risk: stability strategy, chamber qualification, documentation quality, remediation, and inspection defense.
ICH Q1A program design, stability strategy, excursion justification, and regulatory support.
Validation assessment, IQ/OQ/PQ protocol authoring, mapping strategy, and report remediation.
cGMP quality system development, SOP authoring, document control, and governance frameworks.
Gap assessment, CAPA strategy, system correction, and inspection-risk reduction.
FDA inspection preparation, mock audits, documentation review, and response strategy.
Scientific temperature excursion assessment, MKT modeling, and deviation justification.
Concentric does not operate storage facilities, courier services, distribution services, or 3PL activities. That independence allows objective assessment of stability programs, storage vendors, quality agreements, documentation systems, and regulatory boundaries.
Why it matters: clients receive independent recommendations without a commercial incentive to steer product into a Concentric storage network.
Discuss stability program design, validation strategy, SOP development, remediation, or inspection readiness support.